Washington State www.EmploymentCrossing.com $ 1,200,000 $ 60,000,000 dollars as part of the solution to Pfizer of the 33 public sector commercial practices potentially dangerous. The agreement ends five-year investigation into allegations that he has the anti-inflammatory drugs Celebrex and Bextra to use, transport approved, despite the known health risks. "This is not only misleading marketing," off-label "marketing, a possible risk to patients," to create, Washington Attorney GeneralRob McKenna told the Seattle Post-Intelligencer. settlement money will be used for legal fees, enforcement of consumer protection and education. The alleged that despite the fact that significant safety concerns led the FDA to a high dose Bextra for acute pain and the market has refused the request of the surgery by Pfizer conducted an aggressive campaign to market the drug to unauthorized purposes. The Company charges sales representatives to promote Bextra off-label applications, promotion, corruption influentialPaid consultants, doctors and the full weekend of high-end system, supported and guided Bextra off-label use in educational programs for physicians. In the village Pfizer is responsible for checking the FDA approval sent to television advertising to consumers. New York is the total sales for Pfizer Pharmaceuticals. For more information on jobs in the region can be found here.
Keywords: Washington, Seattle, Post-Intelligencer, Attorney, General, Rob, mckenna, Bextra, Pfizer, FDA
Lester Buildings Ultrasonic Flowmeter Weedeater Featherlite fl20
No comments:
Post a Comment